"Evaluation Of compliance To Iron Chelation Therapy With Defe-Roxamine In Patients With Major Thalassemia In Iran In 2004 "

Background and Aim: With the introduction of long term subcutaneous administration of Deferoxamine there has been a decline in the morbidity and mortality of transfusion-dependent beta thalassemia patients. But parenteral iron chelation therapy is still a burden and a major reason for unsatisfactory...

Full description

Bibliographic Details
Main Authors: M. Izadyar, L. Sedighipourand H. Jafarieh
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2006-06-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/2621.pdf&manuscript_id=2621